Related Experiment Video
Updated: Jul 2, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
How does anger coping style affect glycemic control in diabetes patients?
Joyce P Yi1, Jean C Yi, Peter P Vitaliano
1Department of Endocrinology/Diabetes, Children's Hospital and Regional Medical Center, Seattle, WA, USA.
International Journal of Behavioral Medicine
|August 13, 2008
Summary
Higher anger coping in diabetes patients may worsen glycemic control by increasing distress. This study explored anger, distress, and HbA1c in 100 diabetes patients over 12 months.
Area of Science:
- Psychology
- Endocrinology
- Health Psychology
Background:
- Anger impacts health in chronic illnesses, but its role in diabetes is understudied.
- Understanding anger's effects is crucial for managing diabetes.
- This study investigates anger coping in diabetes patients.
Purpose of the Study:
- To examine associations between anger coping style, psychological distress, and HbA1c in diabetes patients.
- To determine if anger coping influences glycemic control.
- To explore the mediating role of distress in this relationship.
Main Methods:
- 100 diabetes patients completed questionnaires on anger coping and diabetes distress.
- Glycosylated hemoglobin (HbA1c) levels were measured at baseline, 6 months, and 12 months.
- Linear regression analyses were used to assess associations and mediation.
Main Results:
- Anger coping style at baseline predicted higher HbA1c levels at 12 months.
- Diabetes-related psychological distress at 6 months partially mediated the link between anger coping and later HbA1c.
- No association was found between baseline HbA1c and later anger coping.
Conclusions:
- Higher anger coping may lead to poorer glycemic control in diabetes.
- This effect appears to be mediated by increased diabetes-related distress.
- Future research should explore interventions targeting anger in diabetes management.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...